In a groundbreaking move, Morgan Stanley is set to allow its financial advisors to offer bitcoin ETFs to select clients. This decision marks a significant shift in the stance of major Wall Street banks towards the cryptocurrency landscape. Morgan Stanley’s 15,000 financial advisors will now be able to recommend eligible clients to invest in the
Business
Eli Lilly’s weight loss drug Zepbound has shown significant benefits in patients with a common type of heart failure and obesity, as per the late-stage trial data released by the company. The findings reveal that Zepbound, along with other popular GLP-1 drugs, offers health advantages beyond weight loss promotion and blood sugar regulation. The study